Time Gained With Long-term Fremanezumab Treatment in Patients With Chronic and Episodic Migraine

被引：0
|
作者：
Marmura, M. [1 ]
Cohen, J. M. [2 ]
Ning, X. [2 ]
Campos, V. Ramirez [2 ]
Barash, S. [2 ]
Goadsby, P. J. [3 ,4 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[2] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[3] Kings Coll Hosp London, London, England
[4] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0323
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [1] Time Gained With Long-term Fremanezumab Treatment in Patients With Chronic and Episodic Migraine
    Marmura, M.
    Cohen, J. M.
    Ning, X.
    Campos, V. Ramirez
    Barash, S.
    Goadsby, P. J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 117 - 117
  • [2] Long-term Efficacy of Fremanezumab in Patients With Chronic or Episodic Migraine Who Were Inadequate Responders to Initial Fremanezumab Treatment
    Silberstein, Stephen D.
    Ortega, Mario
    Elms, Shawn
    Davis, Matthew
    Cohen, Joshua M.
    Seminerio, Michael
    Gross, Nick
    Blumenfeld, Andrew
    [J]. NEUROLOGY, 2021, 96 (15)
  • [3] Long-Term Efficacy of Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification
    Lipton, Richard
    Cohen, Joshua
    Yeung, Paul P.
    Yang, Ronghua
    Seminerio, Michael
    Campos, Verena Ramirez
    Singh, Rashmi Halker
    Ailani, Jessica
    [J]. NEUROLOGY, 2019, 92 (15)
  • [4] Long-Term Efficacy of Fremanezumab in Patients Who Reverted from a Chronic to an Episodic Migraine Classification
    Lipton, R. B.
    Cohen, J. M.
    Yang, R.
    Seminerio, M. J.
    Campos, V. Ramirez
    Singh, R. B. Walker
    Ailani, J.
    [J]. HEADACHE, 2019, 59 : 101 - 102
  • [5] Efficacy of Long-Term Fremanezumab Treatment in Patients with Chronic or Episodic Migraine and Prior Inadequate Response to Multiple Migraine Preventive Medication Classes
    Naegel, Steffen
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Barash, Steve
    Ning, Xiaoping
    Carr, Karen
    Kudrow, David
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S132 - S133
  • [6] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez-Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S183 - S184
  • [7] Reversion of Patients With Chronic Migraine to an Episodic Migraine Classification With Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Campos, Verena Ramirez
    Singh, Rashmi B. Halker
    Ailani, Jessica
    [J]. NEUROLOGY, 2018, 90
  • [8] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Singh, Halker R. B.
    Cohen, J. M.
    Bibeau, K.
    Galic, M.
    Seminerio, M. J.
    Campos, Ramirez, V
    Ailani, J.
    [J]. HEADACHE, 2018, 58 : 70 - 71
  • [9] Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [10] Fremanezumab as a preventive treatment for episodic and chronic migraine
    Bigal, Marcelo E.
    Walter, Sarah
    Rapoport, Alan M.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 719 - 728
12345